Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Urinary NGF, PGE2 and ATP: Potential Biomarkers for Diagnosis and Prediction of Treatment Efficacy in Overactive Bladder Patients

NCT01499069 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT01499069
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01499069 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Urinary NGF, PGE2 and ATP: Potential Biomarkers for Diagnosis and Prediction of Treatment Efficacy in Overactive Bladder Patients
Lead sponsor
Samsung Medical Center
Phase
Not applicable
Overall status
Completed
Start date
February 28, 2010
Completion date
February 29, 2016
Enrollment
191 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder